World Immunotherapy Council (WIC)

Participating Organizations

WIC Activities

  • Adoptive Engineered T Cell Targeting to Activate Cancer Killing (ATTACK)
  • Association for Cancer Immunotherapy Immunoguiding (CIMT)
  • Australian Group
  • Canadian Cancer Immunotherapy Consortium (CCIC)
  • Cancer Drug Development Forum (CDDF), Formerly: Biotherapy Development Association (BDA)
  • Chinese Society of Clinical Oncology
  • Committee for Tumor Immunology and Bio-Therapy
  • Dutch Tumor Immunology Working Party
  • European Academy of Tumor Immunology
  • European Society of Cancer Immunology and Immunotherapy
  • German Cancer Immunology group in the German Immunology Society
  • Italian Network for Tumor Biotherapy
  • Japanese Association of Cancer Immunotherapy
  • Middle Eastern and North African Interest Group
  • National Institute of Oncology, Budapest
  • Progress in Vaccination Against Cancer
  • Scandinavian Network for Immunotherapy of Cancer
  • Society for Immunotherapy of Cancer
  • Tumor Immunology Meets Oncology
  • Tumor Vaccine and Cell Therapy Working Group

Defining the Critical Hurdles in Cancer Immunotherapy

SITC strives to launch effective initiatives in order to accelerate the delivery of new immunotherapies to cancer patients around the world. In an effort led by SITC Past President, Bernard Fox, PhD, a collaborative group of international and domestic organizations similarly interested in promoting research and translation of cancer immunotherapy prepared a joint publication that defines the critical hurdles in cancer immunotherapy. This manuscript was published in the Journal of Translational Medicine. To access the full manuscript, click here.

2012 World Immunotherapy Council Summit in Curacao

In an exciting and first-of-its-kind collaboration, SITC convened the World Immunotherapy Council (WIC) inaugural summit February 21-24, 2012 in Curacao.  Scientific sessions at the meeting focused on several of the hurdles identified in the "Defining the Critical Hurdles in Cancer Immunotherapy" manuscript (see above), including mechanisms of immune escape, immunological monitoring, and prognostic and predictive biomarkers. This summit provided a forum to facilitate the rapid development and global dissemination of cancer immunotherapies through international scientific exchange.